Current challenges facing the clinical treatment for HTLV-1 ocular manifestations
K Kamoi - Expert Review of Ophthalmology, 2023 - Taylor & Francis
Introduction Human T-lymphotropic virus type 1 (HTLV-1) is a lifelong persistent retrovirus
associated with numerous systemic and ocular diseases, presenting significant clinical …
associated with numerous systemic and ocular diseases, presenting significant clinical …
[HTML][HTML] Intravitreal lupeol: A new potential therapeutic strategy for noninfectious uveitis
CR Toledo, MRB Paiva, BFM Castro, VV Pereira… - Biomedicine & …, 2021 - Elsevier
Lupeol is a pentacyclic triterpene with known anti-inflammatory effects. However, its role in
the treatment of noninfectious uveitis has not been explored. This work investigated anti …
the treatment of noninfectious uveitis has not been explored. This work investigated anti …
The suppressive effect of triptolide on experimental autoimmune uveoretinitis by down-regulating Th1-type response
Y Wu, Y Wang, C Zhong, Y Li, X Li, B Sun - International …, 2003 - Elsevier
We investigated the suppressive effect of triptolide (TRD), a purified component from a
traditional Chinese herb, Tripterygium wilfordii Hook F.(TWHf), on uveitogenic peptide (K2) …
traditional Chinese herb, Tripterygium wilfordii Hook F.(TWHf), on uveitogenic peptide (K2) …
Vorinostat modulates the imbalance of T cell subsets, suppresses macrophage activity, and ameliorates experimental autoimmune uveoretinitis
S Fang, X Meng, Z Zhang, Y Wang, Y Liu, C You… - Neuromolecular …, 2016 - Springer
The purpose of the study was to investigate the anti-inflammatory efficiency of vorinostat, a
histone deacetylase inhibitor, in experimental autoimmune uveitis (EAU). EAU was induced …
histone deacetylase inhibitor, in experimental autoimmune uveitis (EAU). EAU was induced …
Tackling HTLV-1 infection in ophthalmology: a nationwide survey of ophthalmic care in an endemic country, Japan
K Kamoi, A Okayama, S Izumo, I Hamaguchi… - British Journal of …, 2020 - bjo.bmj.com
Introduction Japan is the most endemic of the developed nations in terms of human T-
lymphotropic virus type 1 (HTLV-1) infection. Japan has been tackling HTLV-1 infection and …
lymphotropic virus type 1 (HTLV-1) infection. Japan has been tackling HTLV-1 infection and …
[HTML][HTML] Safety of Infliximab for the Eye Under Human T-Cell Leukemia Virus Type 1 Infectious Conditions in vitro
M Uchida, K Kamoi, N Ando, C Wei, H Karube… - Frontiers in …, 2019 - frontiersin.org
Use of biologics has been widely advocated for inflammatory diseases recently. Anti-tumor
necrosis factor (TNF)-α antibody therapy is reportedly effective against ocular inflammation …
necrosis factor (TNF)-α antibody therapy is reportedly effective against ocular inflammation …
Evaluating tocilizumab safety and immunomodulatory effects under ocular HTLV-1 infection in vitro
J Zhang, K Kamoi, Y Zong, M Yang, Y Zou… - International …, 2024 - Elsevier
There is growing interest in evaluating the safety and therapeutic potential of existing
treatments such as tocilizumab (TCZ), an IL-6 receptor antagonist used to treat inflammatory …
treatments such as tocilizumab (TCZ), an IL-6 receptor antagonist used to treat inflammatory …
[HTML][HTML] HTLV-1 in ophthalmology
K Kamoi - Frontiers in Microbiology, 2020 - frontiersin.org
Human T-cell leukemia virus type 1 (HTLV-1) was the first retrovirus described as a
causative agent for human disease. In the field of ophthalmology, a close relationship …
causative agent for human disease. In the field of ophthalmology, a close relationship …
[HTML][HTML] Comparison of intraocular pressure-lowering effects of ripasudil hydrochloride hydrate for inflammatory and corticosteroid-induced ocular hypertension
M Yasuda, K Takayama, T Kanda, M Taguchi… - PLoS …, 2017 - journals.plos.org
Ocular hypertension (OHT) caused by inflammation or corticosteroid treatment is a common
complication of uveitis. Ripasudil hydrochloride hydrate (K-115) is reportedly efficacious for …
complication of uveitis. Ripasudil hydrochloride hydrate (K-115) is reportedly efficacious for …
[HTML][HTML] Intraocular DHODH-inhibitor PP-001 suppresses relapsing experimental uveitis and cytokine production of human lymphocytes, but not of RPE cells
M Diedrichs-Möhring, S Niesik, CS Priglinger… - Journal of …, 2018 - Springer
Background Uveitis is a potentially blinding inflammatory disease of the inner eye with a
high unmet need for new therapeutic interventions. Here, we wanted to investigate the …
high unmet need for new therapeutic interventions. Here, we wanted to investigate the …